Hausstaubmilbe (D. Farinae) Bencard Allergie

Hausstaubmilbe (D. Farinae) Bencard Allergie is an allergen extract containing Dermatophagoides farinae (house dust mite) as the active ingredient. It is supplied without a specified strength or dosage form and is intended for intraepidermal administration as part of allergy immunotherapy. The product is marketed in the European Union and is used primarily for diagnostic skin testing and controlled exposure in allergic rhinitis and asthma caused by dust‑mite allergens.

Hausstaubmilbe (D. Farinae) Bencard Allergie is employed in clinical settings to manage reactions to the house dust mite Dermatophagoides farinae. It is used both for diagnostic skin testing and for initiating allergen‑specific immunotherapy in patients with confirmed sensitivity. - Diagnosis of allergic rhinitis caused by Dermatophagoides farinae through skin prick testing. - Assessment of allergic asthma triggered by Dermatophagoides farinae using intraepidermal testing. - Initiation of allergen‑specific immunotherapy for dust‑mite‑induced respiratory allergies. - Monitoring of immunotherapy response by periodic controlled exposure. - Research applications involving controlled exposure to Dermatophagoides farinae extract.

Side effects associated with Hausstaubmilbe (D. Farinae) Bencard Allergie reflect the local and systemic responses that can occur after intraepidermal exposure to the dust‑mite extract. These effects can vary depending on individual sensitivity and the administered dose. Common: - Mild erythema or redness at the injection site. - Transient itching or localized swelling. - Temporary nasal congestion or sneezing. - Light‑headedness or mild headache. Serious: - Anaphylactic reaction requiring emergency medical care. - Severe bronchospasm or asthma exacerbation. - Systemic urticaria or angioedema. - Rapid drop in blood pressure (hypotension).

When using Hausstaubmilbe (D. Farinae) Bencard Allergie, clinicians should observe several precautions to minimize risk and ensure appropriate patient selection. - Perform a thorough allergy history and confirm Dermatophagoides farinae sensitivity before administration. - Conduct skin testing in a controlled setting with emergency equipment readily available. - Avoid use in patients with a history of severe anaphylaxis to dust‑mite extracts. - Assess asthma control; unstable asthma is a contraindication for initiation. - Pregnant or lactating individuals should be evaluated on a case‑by‑case basis. - Document all reactions and adjust the immunotherapy schedule accordingly.

Hausstaubmilbe (D. Farinae) Bencard Allergie may interact with other medications or substances that influence immune response or increase the risk of allergic reactions. Avoid: - Concurrent use of beta‑blockers, which can blunt response to epinephrine during anaphylaxis. - Ongoing treatment with systemic immunosuppressants that may reduce immunotherapy efficacy. - High‑dose aspirin or NSAIDs that can potentiate allergic responses. Use with caution: - Antihistamines, which may mask early signs of a reaction; monitor patient closely. - ACE inhibitors, as they can exacerbate angioedema in susceptible individuals. - Other allergen extracts administered within a short interval; space administrations to avoid cumulative reactions.